Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Clasificación en acciones #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Precio por acción
$1.50
Última sincronización: 2026-09-21
Capitalización bursátil
$3.63M
Cambio (1 día)
-4.46%
Cambio (1 año)
-72.68%
País
MY
Comercio BioNexus Gene Lab Corp. (BGLC)

Categoría

Ratio P/S de BioNexus Gene Lab Corp. (BGLC)
Ratio P/S al September 2026 TTM: 1.16
Según los informes financieros más recientes y el precio de las acciones de BioNexus Gene Lab Corp., el ratio P/S actual (TTM) es 1.16. Al final de 2023, el ratio P/S era 0.93.
Historial del ratio P/S de BioNexus Gene Lab Corp. desde 2016 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 1.16 123.02%
2024 0.52 -43.84%
2023 0.93 -93.79%
2022 15.03 -44.95%
2021 27.30 37.30%
2020 19.89 -98.67%
2019 1.50K 117.75%
2018 687.59 -54.92%
2017 1.53K 0.00%
2016 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
3.20 175.99%
US
6.48 459.13%
US
- -
US
0.66 -43.43%
US
- -
US